BRIEF published on 07/02/2025 at 06:50, 5 months 2 days ago Galenica Acquires Labor Team to Enter Diagnostics Business Acquisition Galenica Diagnostics Healthcare Network Labor Team
PRESS RELEASE published on 07/02/2025 at 06:45, 5 months 2 days ago Galenica to enter the diagnostics business by acquiring Labor Team Galenica AG acquires Labor Team, a leading Swiss diagnostic service provider, expanding its offerings in the physicians segment and entering the diagnostics business Acquisition Galenica AG Healthcare Network Labor Team Diagnostics Business
BRIEF published on 05/22/2025 at 06:50, 6 months 13 days ago Galenica Reports Solid Sales Growth in Early 2025 Retail Expansion Pharmaceutical Market Logistics & IT Galenica Growth Products & Care
PRESS RELEASE published on 05/22/2025 at 06:45, 6 months 13 days ago Galenica continues sales growth Galenica reports 4.7% sales growth to CHF 1,314.2 million in 2025, outperforming the pharmaceutical market. Guidance confirms sales growth of 3-5% and EBIT growth of 4-6% Sales Growth EBIT Growth Galenica Pharmaceutical Market 2025 Outlook
BRIEF published on 04/10/2025 at 18:17, 7 months 24 days ago Galenica Annual General Meeting Embraces All Motions Switzerland Dividend Increase Board Elections Galenica AGM 2025
PRESS RELEASE published on 04/10/2025 at 18:12, 7 months 24 days ago Galenica Annual General Meeting approves all motions and elects new member of the Board of Directors Galenica Annual General Meeting approves all motions, elects new Board member, and approves dividend increase. Shareholders demonstrate confidence in leadership and strategic direction Board Of Directors Annual General Meeting Dividend Increase AGM Galenica
BRIEF published on 03/11/2025 at 06:50, 8 months 24 days ago Solid performance and promising outlook for Galenica in 2024 Financial Growth Home Care Digital Innovation Galenica Pharmacies In Switzerland
PRESS RELEASE published on 03/11/2025 at 06:45, 8 months 24 days ago Galenica continues to grow in 2024 Galenica Group reports strong growth in 2024 financial year, with sales up 4.7% to CHF 3,921.1 million. Adjusted EBIT increases by 10.3%. Guidance for 2025 includes sales growth of 3-5% Financial Results Sales Growth 2024 2025 Galenica Group
BRIEF published on 01/23/2025 at 07:05, 10 months 12 days ago Galenica Nominates Nadine Balkanyi-Nordmann for Board of Directors Legal Expertise ESG Compliance Galenica AG Board Nomination Nadine Balkanyi-Nordmann
PRESS RELEASE published on 01/23/2025 at 07:00, 10 months 12 days ago Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors Galenica nominates Nadine Balkanyi-Nordmann, legal and compliance expert, for the Board of Directors. The upcoming AGM aims to strengthen governance and risk management Board Of Directors Compliance AGM Galenica Nadine Balkanyi-Nordmann
Published on 12/05/2025 at 02:35, 2 hours 46 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 21 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 16 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 21 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 51 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 30 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 56 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 6 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 11 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 21 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 36 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 37 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 20 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
